Morfina
| |
| 7,8-didehydro-4,5-epoxy- 17-methylmorphinan-3,6-diol | |
| CAS number 57-27-2 (anhydrous) | ATC code N02AA01 |
| Chemical formula | C17H19NO3 |
| SMILES | CN1CCC23C4C1Cc5c2c(c(cc5)O)OC3C(O)C=C4 |
| Molecular weight | 285.4 |
| Bioavailability | ~30% (oral route) |
| Metabolism | renal 90%, biliary 10% |
| Elimination half-life | 2–3 hours |
| Excretion | renal 90%, biliary 10% |
| Pregnancy category | Category C (Australia) |
| Legal status | Schedule 8 (Australia), Class A (UK), DEA C-II (USA), Schedule I (Canada) |
| Routes of administration | oral, SC, IM, IV |
| Dependence Liability | Extremely High |
Ti morfina, ti principal nga aktibo nga ahente iti apiang (opio), ket maysa a nabileg nga opioid analgesic a droga.
Ti balikas a "morfina" ket nagtaud iti Morpheus, ti didiosen ti tagainep iti mitolohia a Griego.